Pier 88 Investment Partners’s Heron Therapeutics HRTX Stock Holding History

Pier 88 Investment Partners’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-60,000	Closed	-$150K	–	93
2022 Q4	$150K	Buy	60,000 +32,300	+117%	+$104K	0.04%	82
2022 Q3	$117K	Buy	27,700 +27,000	+3,857%	+$106K	0.03%	91
2022 Q2	$2K	Sell	700 -135,630	-99%	-$545K	﹤0.01%	102
2022 Q1	$780K	Buy	136,330 +37,500	+38%	+$274K	0.28%	65
2021 Q4	$902K	Buy	98,830 +51,900	+111%	+$530K	0.19%	78
2021 Q3	$502K	Buy	46,930 +3,320	+8%	+$40.4K	0.15%	91
2021 Q2	$677K	Hold	43,610	–	–	0.19%	89
2021 Q1	$707K	Sell	43,610 -4,800	-10%	-$85.6K	0.24%	78
2020 Q4	$1.02M	Buy	48,410 +10,730	+28%	+$186K	0.33%	62
2020 Q3	$558K	Sell	37,680 -20,146	-35%	-$314K	0.17%	91
2020 Q2	$850K	Buy	57,826 +12,356	+27%	+$203K	0.24%	82
2020 Q1	$534K	Buy	45,470 +16,600	+57%	+$312K	0.19%	73
2019 Q4	$678K	Sell	28,870 -16,500	-36%	-$365K	0.27%	52
2019 Q3	$839K	Buy	45,370 +10,785	+31%	+$198K	0.33%	50
2019 Q2	$643K	Sell	34,585 -790	-2%	-$15.8K	0.27%	63
2019 Q1	$865K	Buy	35,375 +13,870	+64%	+$363K	0.4%	44
2018 Q4	$558K	Buy	21,505 +4,400	+26%	+$121K	0.28%	50
2018 Q3	$541K	Buy	17,105 +5,490	+47%	+$204K	0.24%	59
2018 Q2	$451K	Buy	+11,615	New	+$370K	0.21%	63

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Pier 88 Investment Partners's HRTX Position: Q1 2023 in Review

Pier 88 Investment Partners sold out of Heron Therapeutics (HRTX) in Q1 2023, closing a stake of 60,000 shares — an estimated $150K sold.

Pier 88 Investment Partners first reported a position in HRTX in Q2 2018 and held it in 19 quarters. The position peaked at $1.02M in Q4 2020. 162 funds tracked by Wall St. Rank hold HRTX as of Q1 2023.

Pier 88 Investment Partners reported no remaining Heron Therapeutics position as of Q1 2023 after selling out during the quarter.
Pier 88 Investment Partners sold 60,000 Heron Therapeutics shares in Q1 2023, an estimated $150K.
Pier 88 Investment Partners first reported a position in Heron Therapeutics in Q2 2018 and held it in 19 quarters.
Pier 88 Investment Partners's Heron Therapeutics position peaked at $1.02M in Q4 2020.
162 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2023.

Based on Pier 88 Investment Partners's 13F filing for Q1 2023, filed 9 May 2023.